KMT2A and tauopathy: At the same time, chromatin-modifying enzymes such as KMT2A (MLL1), BRD4, and EP300 are mis-routed in different tauopathy models to either eu-nuclear or nucleolar compartments, which fuel enhanced TWNI productivity into stimulus-responsive enhancers [97].